Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Cardiovascular Diabetology|March 27, 2019
The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese ratJavad Habibi, Annayya R Aroor, Nitin A Das, et al.
Scientific Reports|June 3, 2020
Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast CancerEckhard U Alt, Philipp M Wörner, Andreas Pfnür, et al.
Hypertension (Dallas, Tex. : 1979)|August 25, 2020
TRAF3IP2 (TRAF3 Interacting Protein 2) Mediates Obesity-Associated Vascular Insulin Resistance and Dysfunction in Male MiceZachary I Grunewald, Francisco I Ramirez-Perez, Makenzie L Woodford, et al.
Journal of Cellular Physiology|May 11, 2019
RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferationSrinivas Mummidi, Nitin A Das, Andrea J Carpenter, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 13, 2024
Chronic intermittent hypoxia facilitates the development of angiotensin II-induced abdominal aortic aneurysm in male miceNeekun Sharma, Abdelnaby Khalyfa, Dunpeng Cai, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 4, 2025
Loss of Hepatocyte-Specific RECK Exacerbates Metabolic Dysfunction-Associated SteatohepatitisRyan J Dashek, Taylor J Kelty, Rory P Cunningham, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018
SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes AtherosclerosisSergiy Sukhanov, Yusuke Higashi, Shaw-Yung Shai, et al.
The Journal of Biological Chemistry|July 29, 2016
Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and DysfunctionManjunath Yariswamy, Tadashi Yoshida, Anthony J Valente, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 26, 2024
Hepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis DevelopmentRyan J Dashek, Rory P Cunningham, Christopher L Taylor, et al.
Endocrinology|October 5, 2017
Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male MiceScott M Brown, Cassandra E Smith, Alex I Meuth, et al.
Pageof 11